AbbVie boosts 2019 profit outlook as Humira helps beat revenue estimates
AbbVie Inc posted quarterly sales above estimates on Friday and raised the lower end of its 2019 profit forecast, getting a boost from strong demand for cancer medicine Imbruvica and a lower-than-expected drop in bestseller Humira's revenue.